Studies in animal models with human-like lipoprotein metabolism have suggested that Lp-PLA2 activity contributes to atherosclerosis development, and epidemiological studies have presented evidence that circulating concentrations of Lp-PLA2 or elevated activity of the enzyme are associated with cardiovascular disease after adjusting for established risk factors [1]–[3]. Here, PLA2G7 is linked to atherosclerosis.